Cargando…

Single use bioreactors for the clinical production of monoclonal antibodies – a study to analyze the performance of a CHO cell line and the quality of the produced monoclonal antibody

Detalles Bibliográficos
Autores principales:	Diekmann, Sonja, Dürr, Constanze, Herrmann, Alexander, Lindner, Ingo, Jozic, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284970/ https://www.ncbi.nlm.nih.gov/pubmed/22373057 http://dx.doi.org/10.1186/1753-6561-5-S8-P103

Ejemplares similares

Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor™
por: Clincke, Marie-Françoise, et al.
Publicado: (2011)

Medium and feed optimization for fed-batch production of a monoclonal antibody in CHO cells
por: Kochanowski, Nadine, et al.
Publicado: (2011)

Analysis of glycolytic flux as a rapid screen to identify low lactate producing CHO cell lines with desirable monoclonal antibody yield and glycan profile
por: Legmann, Rachel, et al.
Publicado: (2011)

Use of Micro Bioreactor systems to streamline cell line evaluation and upstream process development for monoclonal antibody production
por: Warr, Steve R C, et al.
Publicado: (2011)

Preliminary evaluation of microcarrier culture for growth and monoclonal antibody production of CHO-K1 cells
por: Rodrigues, M Elisa, et al.
Publicado: (2011)

Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform
por: Ghorbaniaghdam, Atefeh, et al.
Publicado: (2014)

Correction: Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform
Publicado: (2014)

Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events
por: Fratz‐Berilla, Erica J., et al.
Publicado: (2020)

Multi-omics approach for comparative studies of monoclonal antibody producing CHO cells
por: Orellana, Camila A, et al.
Publicado: (2015)

Stress‐induced increase of monoclonal antibody production in CHO cells
por: Schellenberg, Jana, et al.
Publicado: (2022)

Determination of intracellular antibody production, cell density, and viability of recombinant CHO-DG44 cells using the MACSQuant® Analyzer
por: Pluschke, Jörn, et al.
Publicado: (2011)

Platform process for production of monoclonal antibodies for research purposes – improvement option
por: Petersen, Joern Meidahl, et al.
Publicado: (2011)

Amino acid consumption in naïve and recombinant CHO cell cultures: producers of a monoclonal antibody
por: Carrillo-Cocom, L. M., et al.
Publicado: (2014)

Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
por: Landauer, Karlheinz, et al.
Publicado: (2011)

Bioreactor cultivation of CHO DP-12 cells under sodium butyrate treatment – comparative transcriptome analysis with CHO cDNA microarrays
por: Klausing, Sandra, et al.
Publicado: (2011)

Growth and death kinetics of CHO cells cultivated in continuous bioreactor at various agitation rates
por: Balandras, Frédérique, et al.
Publicado: (2011)

Trends in Monoclonal Antibody Production Using Various Bioreactor Systems
por: Jyothilekshmi, I., et al.
Publicado: (2021)

Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies
por: Noh, Soo Min, et al.
Publicado: (2018)

Novel application of anti‐human Fc nanobody for screening high‐producing CHO cells for monoclonal antibody
por: Zhu, Di, et al.
Publicado: (2022)

Characterization of binding interactions in solution between β-2-glycoprotein I and monoclonal antibodies
por: Heegaard, NHH, et al.
Publicado: (2002)

Anti-Ige monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review
por: Hong, Chris J, et al.
Publicado: (2014)

Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line
por: Voronina, E. V., et al.
Publicado: (2016)

Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
por: Mullan, Brian, et al.
Publicado: (2011)

Immunodiagnosis and therapeutic immunosuppression in rheumatoid arthritis with ior t1 (anti-CD6) monoclonal antibody
por: Montero, E, et al.
Publicado: (2002)

Transient gene expression with CHO cells in conditioned medium: a study using TubeSpin(®) bioreactors
por: Pereira, João, et al.
Publicado: (2011)

Allergic diseases of the skin and drug allergies – 2017. Rapid desensitization for delayed reactions to chemotherapy and monoclonal antibodies
por: Vega Castro, Maria Aranzazu, et al.
Publicado: (2013)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Screening Naturally Occurring Phenolic Antioxidants for Their Suitability as Additives to CHO Cell Culture Media Used to Produce Monoclonal Antibodies
por: Toronjo-Urquiza, Luis, et al.
Publicado: (2019)

EHMTI-0315. AMG 334, the first potent and selective human monoclonal antibody antagonist against the CGRP receptor
por: Xu, C, et al.
Publicado: (2014)

Anti-Ige monoclonal antibody therapy for the treatment of patients with chronic rhinosinusitis: a multi-disciplinary practice review
por: Kilty, Shaun J, et al.
Publicado: (2014)

Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody
por: Chromikova, Veronika, et al.
Publicado: (2017)

CHO cell lines generated by PiggyBac transposition
por: Matasci, Mattia, et al.
Publicado: (2011)

Using simple models to describe the kinetics of growth, glucose consumption, and monoclonal antibody formation in naive and infliximab producer CHO cells
por: López-Meza, Julián, et al.
Publicado: (2015)

Plant-Produced Monoclonal Antibody as Immunotherapy for Cancer
por: Nessa, Meher Un, et al.
Publicado: (2020)

Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4.
por: Efferth, T., et al.
Publicado: (1991)

Reduction in C-terminal amidated species of recombinant monoclonal antibodies by genetic modification of CHO cells
por: Škulj, Mihaela, et al.
Publicado: (2014)

Successful development of novel monoclonal antibodies against HTLV-1 bZIP factor and their applications in studying the pathogenesis of HAM/TSP
por: Saito, Mineki, et al.
Publicado: (2011)

Development and fine-tuning of a scale down model for process characterization studies of a monoclonal antibody upstream production process
por: Harmsen, Mareike, et al.
Publicado: (2011)

Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines
por: Manieri, Tania Maria, et al.
Publicado: (2022)

Increasing antibody yield and modulating final product quality using the Freedom(TM) CHO-S(TM) production platform
por: Sabourin, Michelle, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7c9jgr5453f7locc7va59a5egf